3. Case 1
• 69 y/o M with NSTEMI is going for PCI.
Baseline Cr 65. 2 days post PCI Cr is 94 with
good UOP .
• Are you concerned about what happened?
4. Case 2
• 42 y/o F in 5C3 with T2 DM with baseline Cr
of 60 she is scheduled for CT abdomen for
pancreatitis .
• What is her risk of developing CIN?
5. Case 3
• 78 y/o came with IWMI with hypotension
required IABP and pressors is going for
diagnostic angiogram after successful lytic
therapy . Known DM with Cr 150 ,he is
concerned about his kidneys .
• Is there a way to predict his risk ?
6. Case 4
• 65 y/o F smoker ,T2 DM with Cr 100,HTN and
sever PVD underwent 1ry PCI for AWMI. Next
day Cr 200 and you notice periphral cynosis
with rash over Rt leg.
• What is happening with her?
7. Types of radiocontrast agents
• First generation agents are ionic hyperosmolal
monomers( 1500)
• Second generation agents are nonionic
monomers with a lower osmolality than the
first generation (600)
• The nonionic contrast agents are dimers with
an osmolality ( 350)
8. Definition
25% rise in serum creatinine during the first
three days after the procedure is the most
acceptable definition .
9. Prognosis
• Peak in 1-3 days
• Recovery 5-10
• If creatinine >440 moslt likely progress to RF
requiring HD.
10. PATHOGENESIS
The exact mechanism is not well understood .
The two major theories, based mainly on animal
studies:
renal vasoconstriction(endothelin)
direct toxic effects of the contrast agents.
11. INCIDENCE AND RISK FACTORS
The reported incidence of radiocontrast-
induced nephropathy varies widely, ranging
from 0- 50%.
12. Who is in risk
• Underlying renal insufficiency, with the plasma
creatinine exceeding 132 µmol/L(4-11%) and 50% if
exceeding 350µmol/L.
• Diabetic nephropathy with renal insufficiency (9-
30%)
• Multiple myeloma (1.5%)
• Advanced heart failure or other cause of reduced
renal perfusion such as hypovolemia
• High total dose of contrast agent and the type of
the contrast
14. In PCI
In a review of over 7500 patients undergoing a
PCI for coronary heart disease, the incidence
of CIN was 3.3 percent overall and
approximately 25 percent in those with a
baseline serum creatinine above (177 µmol/L)
.
18. Oral hydration
• Few small trials have evaluated the
effectiveness of oral hydration or an
outpatient hydration protocol in preventing
contrast nephropathy.
• The results have been conflicting, some
suggested that oral hydration as effective
others less effective .
19. Type of fluid
• Prospective randomized trial of 1620
patients . The incidence of contrast-induced
nephropathy was significantly lower in
patients received NS than 1/2NS
20. Acetylcysteine
• There is inconsistency in the results of clinical
trials regarding the effectiveness of NAC in
prevention of contrast nephropathy .
• The overall direction of the data is towards
benefit .
21. NaHCO3
• A prospective, single-center, randomized trial
showed overall benefit of NaHCO3 compared
to NS .
• Issues with this study
22. SUMMARY AND RECOMMENDATIONS
• Indication of the procedure
• The use of lower doses of contrast and avoidance of
repetitive studies that are closely spaced.
• Avoid of volume depletion
• Avoid NSAID
• Stop metformin 48h before
23. Hydration
Prophylactic regimen is the intravenous
administration of NS at a rate of 1 mL/kg /h for 12
hours before and 12 hours after the radiographic
study .
24. NAC
PO: 600 mg orally BID and administered the day
before and the day of the procedure .
IV: 150 mg/kg in 500 mL NS over 30 minutes
immediately before contrast exposure, then
50 mg/kg in 500 mL NS over four hours .
25. NaHCO3
• A bolus of 3 mL/kg of NaHCO3 one hour prior
to the procedure, and continued at a rate of 1
mL/kg for six hours after the procedure.
27. HD and UF
• Creatinine >440
• Decrease UOP
• Acidosis
• Hyperkalemia
28.
29. Case 1
• 62 y/o M with NSTEMI is going for PCI.
Baseline Cr 65. 2 days post PCI Cr is 94 with
good UOP .
• Are you concerned about what happened?
30. Case 2
• 42 y/o F in 5C3 with T2 DM with baseline Cr
of 60 she is scheduled for CT abdomen for
pancreatitis .
• What is her risk of developing CIN?
31. Case 3
• 78 y/o came with IWMI with hypotension
requiring IABP is going for diagnostic
angiogram after successful lytic therapy .
Known DM with Cr 150 is concerned about his
kidney function.
• Is there a way to predict his risk ?
32.
33. Case 4
• 65 y/o F smoker ,T2 DM with Cr 100,HTN and
sever PVD underwent 1ry PCI for AWMI. Next
day Cr 200 and you notice periphral cynosis
with rash over Rt leg.
• What is happening with her?